Cargando…
SARS-CoV-2 anti-spike antibodies after a fourth dose of COVID-19 vaccine in adult solid-organ transplant recipients
BACKGROUND: A fourth dose of SARS-CoV-2 vaccine is recommended in solid-organ transplant (SOT) recipients, but the immunogenicity is poorly known. METHODS: We conducted a retrospective, observational, monocentric study between the 1st January 2021 and 31st March 2022 of the anti-Spike antibody titer...
Autores principales: | Perrier, Quentin, Lupo, Julien, Gerster, Théophile, Augier, Caroline, Falque, Loïc, Rostaing, Lionel, Pelletier, Laurent, Bedouch, Pierrick, Blanc, Myriam, Saint-Raymond, Christel, Boignard, Aude, Bonadona, Agnès, Noble, Johan, Epaulard, Olivier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9444490/ https://www.ncbi.nlm.nih.gov/pubmed/36184404 http://dx.doi.org/10.1016/j.vaccine.2022.08.065 |
Ejemplares similares
-
Atypical Evolution of Secondary Hemolytic Uremic Syndrome Defined as Paraneoplastic Syndrome under Eculizumab and Palbociclib Therapies
por: Perrier, Quentin, et al.
Publicado: (2021) -
A Case of Pneumocystis jirovecii Pneumonia under Belatacept and Everolimus: Benefit-Risk Balance between Renal Allograft Function and Infection
por: Perrier, Quentin, et al.
Publicado: (2021) -
Beaucoup de bruit pour rien : Discordance entre les données historiques de l'efficacité antivirale de l'hydroxychloroquine, son évaluation dans les essais cliniques sur la Covid-19 et sa prescription en ambulatoire
por: Vieux, N., et al.
Publicado: (2023) -
COVID-19 mass vaccination – an illustration of the impact of syringe choice on the effectiveness of mass vaccination campaigns
por: Mazet, Roseline, et al.
Publicado: (2022) -
Immune Response Post–SARS-CoV-2 mRNA Vaccination in Kidney Transplant Recipients Receiving Belatacept
por: Noble, Johan, et al.
Publicado: (2021)